E3 ubiquitin-protein ligase (mouse double minute 2; Mdm2) protein expression is strongly associated with poor overall survival in malignant pleural mesothelioma
F. Mairinger, S. Ting, C. Vollbrecht, R. Walter, J. Kollmeier, S. Grief, T. Hager, T. Mairinger, D. Christoph, K. W. Schmid, J. Wohlschlaeger (Essen, Cologne, Berlin, Germany; Denver, United States Of America)
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Disease area: Thoracic oncology
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Mairinger, S. Ting, C. Vollbrecht, R. Walter, J. Kollmeier, S. Grief, T. Hager, T. Mairinger, D. Christoph, K. W. Schmid, J. Wohlschlaeger (Essen, Cologne, Berlin, Germany; Denver, United States Of America). E3 ubiquitin-protein ligase (mouse double minute 2; Mdm2) protein expression is strongly associated with poor overall survival in malignant pleural mesothelioma. Eur Respir J 2013; 42: Suppl. 57, 543
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
A549 cell expression of ubiquitin E3 ligase RNF168 is decreased following RSV infection but increased by interferon beta treatment Source: Annual Congress 2013 –The burden of respiratory infections in children Year: 2013
The diagnosis and incidence of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase (ALK) mutation in lung adenocarcinoma Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015
Correlation between expression of p53, pRb, mdm2, p21WAF1/CIP1, PCNA, cyclin D1 and apoptotic index (AI) in non-small cell lung cancer (NSCLC) cells Source: Annual Congress 2006 - Molecular pathology and genetics of lung cancer Year: 2006
The proteasome subunits PSMA5 and PSMB4 are potent markers to discriminate between typical and atypical carcinoid tumors of the lung Source: Annual Congress 2013 –Other thoracic tumours, particular circumstances and rare cases Year: 2013
The role of NPM, p14arf and MDM2 in precursors of bronchial squamous cell carcinoma Source: Eur Respir J 2008; 32: 678-686 Year: 2008
BAP1 expression and treatment outcomes in malignant mesothelioma. Source: International Congress 2017 – Pleural disease and mesothelioma: from the bench to the bedside Year: 2017
Loss of orphan G protein coupled receptor GPRC5A is associated with metastatic disease and poor survival in patients with adenocarcinomas of the lung Source: Annual Congress 2011 - Lung cancer: molecular pathology and functional genomics Year: 2011
Akt induced cytoplasmic mislocalization of p27kip1 protein and correlated with poor prognosis in lung adenocarcinoma Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008
Expression of survivin and p53 protein in pulmonary tumours Source: Annual Congress 2011 - Progress in pathology of lung cancer Year: 2011
Translocation of beta-catenin into cytoplasm during TGFbeta-induced EMT is negatively regulated by phosphorylation of the PTEN C-terminus in lung cancers Source: Annual Congress 2013 –Novel in vitro and animal models to study lung diseases Year: 2013
Radiation/cisplatin/vinorelbine therapy increase p53 protein phosphorylated at serine 392 in recurrent primary squamous cell lung cancer Source: Eur Respir J 2001; 18: Suppl. 33, 17s Year: 2001
Therapy increases poly(ADP-ribose), p53 expression, p53-Ser392 –P, and p53-Ser2 –P levels in recurrent squamous cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 14s Year: 2002
An analysis of mRNA and long non-coding RNA (lncRNA) expression during the progression from pre-invasive lesions (PL) to invasive squamous cell carcinoma (SqCC) of the bronchus Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making Year: 2013
Fragile histidine triad protein expression in nonsmall cell lung cancer and correlation with Ki-67 and with p53 Source: Eur Respir J 2003; 21: 753-758 Year: 2003
Nuclear YB-1 expression as a negative prognostic marker in nonsmall cell lung cancer Source: Eur Respir J 2004; 23: 14-19 Year: 2004
Predicting activity of EGFR (epidermal growth factor receptor) inhibitors in diffuse bronchiolo-alveolar carcinoma or so-called pneumonic adenocarcinoma Source: Annual Congress 2006 - Bronchiolo-alveolar carcinoma Year: 2006
Oral presentation: Truncated isoforms of BRCA1-associated protein BARD1 are expressed in NSCLC and are potential targets for treatment Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009
Expression of the ILK-PINCH-PARVIN (IPP) complex and its binding partner Rsu-1 in human non-small cell lung cancer Source: International Congress 2016 – Prognostic variables in lung cancer II Year: 2016
Combined expression of p53, Bcl-2 and p21WAF-1 proteins in endobronchial biopsies may be associated with lung cancer prognosis Source: Eur Respir J 2001; 18: Suppl. 33, 230s Year: 2001
Oncogenic drivers (OD) and matched targeted agents (TA): Impact on overall survival in patients with lung adenocarcinoma (LA)? Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours Year: 2015